By Steve Black2023-12-11T04:00:00
Despite the NHS’s substantial £20bn annual expenditure on drugs and devices, transparency issues persist in understanding hospital medicine budgets, hindering effective analysis and improvement efforts in the face of evolving pharmaceutical pricing agreements, writes Steve Black
Certain articles and Insight pieces remain paying-subscriber only content
As a registered user you will get access to:
Already registered to HSJ? Sign in now
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud